trimethoprim has been researched along with Nasal Catarrh in 2 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Serra, A | 1 |
Tringali, G | 1 |
Toscano, MA | 1 |
Gismondo, MR | 1 |
Piaia, F | 1 |
Mesure, R | 1 |
1 trial available for trimethoprim and Nasal Catarrh
Article | Year |
---|---|
[Double-blind study of the association of sulfamethoxazole and trimethoprim in otorhinolaryngological infections].
Topics: Anti-Infective Agents; Bacterial Infections; Drug Combinations; Drug Synergism; Folic Acid Antagonis | 1973 |
1 other study available for trimethoprim and Nasal Catarrh
Article | Year |
---|---|
[Antibacterial activity of a sulfonamide combination (Kelfiprim) in some otorhinolaryngological diseases].
Topics: Acute Disease; Adolescent; Adult; Bacteria; Bacterial Infections; Chronic Disease; Drug Combinations | 1980 |